Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Now, it could get really interesting

FWIW....ARM's granted reex (Mar. 6, 2008) of the '749 was merged with HTC's and Fish & Richardson's on Sept. 23, 2009 and is in an advanced stage at this point in time. We are awaiting an OA from our response dated Jan 19, 2010 and our IDS's submitted on Feb. 1, 2010.

GLTAL

5
Apr 22, 2010 09:33AM
5
Apr 22, 2010 10:18AM
Share
New Message
Please login to post a reply